Quarterly report pursuant to Section 13 or 15(d)

Stock-based Compensation (Tables)

v3.24.3
Stock-based Compensation (Tables)
9 Months Ended
Sep. 26, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Stock-Based Compensation Expense
The table below presents components of stock-based compensation expense within the Company’s Condensed Consolidated Statements of Operations and Comprehensive Income:
Thirty-nine Weeks Ended
in thousands September 26, 2024 September 28, 2023
General and administrative $ 22,338  $ 18,927 
Selling and store operating 3,280  1,409 
Total stock-based compensation expense $ 25,618  $ 20,336 
Schedule of Stock Option Activity
The table below summarizes stock option activity for the thirty-nine weeks ended September 26, 2024:
Options Weighted Average Exercise Price
Outstanding at December 29, 2023
1,607,341  $ 28.51 
Exercised (331,778) $ 18.72 
Forfeited or expired (2,518) $ 68.82 
Outstanding at September 26, 2024
1,273,045  $ 30.97 
Vested and exercisable at September 26, 2024
1,258,196  $ 30.21 
Schedule of Restricted Stock Unit Activity
The following table summarizes restricted stock unit activity during the thirty-nine weeks ended September 26, 2024:
Restricted Stock Units
Service-based Performance-based Total shareholder return Total Restricted Stock Units
Unvested at December 29, 2023 608,140  188,543  58,854  855,537 
Granted 252,692  50,855  —  303,547 
Vested (214,620) —  —  (214,620)
Forfeited (38,539) (13,838) (4,204) (56,581)
Unvested at September 26, 2024 607,673  225,560  54,650  887,883 
Schedule of Restricted Stock Award Activity
The following table summarizes restricted stock award activity during the thirty-nine weeks ended September 26, 2024:
Restricted Stock Awards
Service-based Performance-based (1) Total shareholder return (1) Total Restricted Stock Awards
Unvested at December 29, 2023 34,783  47,662  31,056  113,501 
Vested (30,680) (47,662) (31,056) (109,398)
Forfeited (395) —  —  (395)
Unvested at September 26, 2024 3,708  —  —  3,708 
(1) The performance-based and total shareholder return restricted stock awards that vested during the period were issued at 100% of target based on achievement of the predetermined performance and total shareholder return criteria as specified in the underlying grant agreements.